Publications by authors named "Ed Wraith"

Claim this Profile
H
High dose genistein in Sanfilippo syndrome: A randomised controlled trial.
Arunabha Ghosh, Stewart Rust, Kia Langford-Smith, Daniel Weisberg, Maria Canal, J Ed Wraith

J Inherit Metab Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier.
Kia J Langford-Smith, Zara Sandiford, Alex Langford-Smith, Fiona L Wilkinson, Simon A Jones, J Ed Wraith

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracolumbar kyphosis in treated mucopolysaccharidosis 1 (Hurler syndrome).
M Naveed Yasin, Raphael Sacho, Neil J Oxborrow, J Ed Wraith, J Bradley Williamson

Spine (Phila Pa 1976)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Large Intragenic Deletion in the ACADM Gene Can Cause MCAD Deficiency but is not Detected on Routine Sequencing.
Claire Searle, Brage Storstein Andresen, Ed Wraith, Jamie Higgs, Deborah Gray

JIMD Rep· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.
Jaap Jan Boelens, Mieke Aldenhoven, Duncan Purtill, Annalisa Ruggeri, Todd Defor, Ed Wraith

Blood· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme replacement therapy and extended newborn screening for mucopolysaccharidoses: opinions of treating physicians.
David J Coman, Ian M Hayes, Veronica Collins, Margaret Sahhar, J Ed Wraith

JIMD Rep· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy.
Muhammad Ameer Saif, Brian W Bigger, Karen E Brookes, Jean Mercer, Karen L Tylee, J Ed Wraith

Haematologica· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB.
Fiona L Wilkinson, Rebecca J Holley, Kia J Langford-Smith, Soumya Badrinath, Aiyin Liao, J Ed Wraith

PLoS One· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases.
Kia Jane Langford-Smith, Jean Mercer, June Petty, Karen Tylee, Heather Church, J Ed Wraith

J Inherit Metab Dis· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece.
Bénédicte Héron, Yann Mikaeloff, Roseline Froissart, Guillaume Caridade, Irène Maire, Ed Wraith

Am J Med Genet A· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease.
Marcelina Malinowska, Fiona L Wilkinson, Kia J Langford-Smith, Alex Langford-Smith, Jillian R Brown, J Ed Wraith

PLoS One· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB.
Maria M Canal, Fiona L Wilkinson, Jonathan D Cooper, J Ed Wraith, Rob Wynn

Behav Brain Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
Kia Langford-Smith, Malani Arasaradnam, J Ed Wraith, Rob Wynn, Brian W Bigger

Mol Genet Metab· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice.
Marcelina Malinowska, Fiona L Wilkinson, William Bennett, Kia J Langford-Smith, H Angharad O'Leary, J Ed Wraith

Mol Genet Metab· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy.
Robert F Wynn, J Ed Wraith, Jean Mercer, Anne O'Meara, Karen Tylee

J Pediatr· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK.
David Moore, Martin J Connock, Ed Wraith, Christine Lavery

Orphanet J Rare Dis· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme replacement therapy for mucopolysaccharidoses: opinions of patients and families.
David J Coman, Ian M Hayes, Veronica Collins, Margaret Sahhar, J Ed Wraith

J Pediatr· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional anesthetic techniques are an alternative to general anesthesia for infants with Pompe's disease.
Robert W M Walker, Geraint Briggs, James Bruce, Joan Fletcher, E D Wraith

Paediatr Anaesth· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on mucopolysaccharidosis type II.
Michael Beck, Ed Wraith

Acta Paediatr· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucopolysaccharidoses and the eye.
Jane L Ashworth, Susmito Biswas, Ed Wraith, I Chris Lloyd

Surv Ophthalmol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I.
Suresh Vijay, J Ed Wraith

Acta Paediatr· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laronidase treatment of mucopolysaccharidosis I.
Ed J Wraith, John J Hopwood, Maria Fuller, Peter J Meikle, Doug A Brooks

BioDrugs· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.
Melissa A Baxter, Robert F Wynn, Simon N Jowitt, J Ed Wraith, Leslie J Fairbairn

Stem Cells· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow.
Robert F Wynn, Claire A Hart, Carla Corradi-Perini, Liam O'Neill, Caroline A Evans, J Ed Wraith

Blood· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.
Shunji Tomatsu, Kazuo Okamura, Takeshi Taketani, Koji O Orii, Tatsuo Nishioka, Ed Wraith

Pediatr Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis